Security Snapshot

CALIDI BIOTHERAPEUTICS, INC. - Common stock, par value $0.0001 per share (CLDI) Institutional Ownership

CUSIP: 320703309

13F Institutional Holders and Ownership History from Q2 2024 to Q4 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$0.59

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / Common stock, par value $0.0001 per share
Symbol
CLDI on NYSE
Shares outstanding
11,128,448
Price per share
$0.59
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • CLDI - CALIDI BIOTHERAPEUTICS, INC. - Common stock, par value $0.0001 per share is tracked under CUSIP 320703309.
  • Latest finished 13F holder period is not available.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 2 to 0 between Q3 2025 and Q4 2025.
  • Reported value moved from $31,797 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Security key

320703309

Latest holder period

n/a

13F holders

13D/G owners

1

CIK / CUSIP context first

CLDI full holder history Calidi Biotherapeutics, Inc. SEC filings Calidi Biotherapeutics, Inc. company facts Calidi Biotherapeutics, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Significant Owners of CALIDI BIOTHERAPEUTICS, INC. - Common stock, par value $0.0001 per share (CLDI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 10% 0% $655,922 -$1,326,278 1,111,732 -67% Armistice Capital, LLC 31 Mar 2026

Institutional Holders of CALIDI BIOTHERAPEUTICS, INC. - Common stock, par value $0.0001 per share (CLDI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$31,797 $0.59 0
2025 Q3 21,074 $31,797 -$953,915 $1.05 2
2025 Q2 2,855,505 $655,824 -$657,230 $0.23 35
2025 Q1 5,458,730 $3,091,541 +$2,351,586 $0.57 35
2024 Q4 1,102,228 $1,266,731 +$901,052 $1.15 33
2024 Q3 318,770 $363,396 +$331,789 $1.14 19
2024 Q2 156,566 $31,312 +$31,312 $0.20 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .